Teva Pharmaceuticals USA Inc recalls Metformin hydrochloride Extended-Release Tablets, 1000 mg, 60-count bottle, RX only, Manufactured by: Actavis Laboratories FL,…

CGMP Deviations: Detection of N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit.

Date

2023-03-15

Country

United States

Brand

Teva Pharmaceuticals

Product

Metformin hydrochloride Extended-Release Tablets, 1000 mg, 60-count bottle, RX only, Manufactured by: Actavis Laboratories FL, Inc., Fort…

Classification

Class II

Units

CA

Category

Drugs & medical

Source

FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

1. Check the product name, strength and lot number against the official notice.
2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More Teva Pharmaceuticals recalls

1. 2023-05-31
2. US
   Drugs & medicalClass III

   Teva Pharmaceuticals USA Inc recalls Fentanyl Buccal Tablets CII, 600mcg, packaged in cartons of 28 Buccal Tablets (4 tablets x 7 cards), Rx only, Distributed by: Mayne…

   Labeling: Incorrect or Missing Package Insert

   FDA · DrugTeva Pharmaceuticals USA IncUS NationwideOfficial notice →
3. 2023-04-12
4. US
   Drugs & medicalClass III

   Teva Pharmaceuticals USA Inc recalls Montelukast Sodium Oral Granules USP, 4 mg, packaged in a carton containing 30 packets, Rx only, Distributed By: Teva…

   Failed Impurities/Degradation Specifications: failed impurities for Sulphoxide and Impurity A.

   FDA · DrugTeva Pharmaceuticals USA IncUSA NationwideOfficial notice →
5. 2023-03-22
6. US
   Drugs & medicalClass II

   Teva Pharmaceuticals USA Inc recalls Clear Eyes, Once Daily, Eye Allergy Itch Relief, olopatadine hydrochloride ophthalmic solution, USP, 0.2%, Antihistamine, 2.5 mL…

   Failed Impurities Specification: Out-of-specification (OOS) stability test result was obtained for unspecified impurity.

   FDA · DrugTeva Pharmaceuticals USA IncNationwide in the U.S.A.Official notice →
7. 2022-09-21
8. US
   Drugs & medicalClass II

   Teva Pharmaceuticals USA Inc recalls Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets (Mixed Salts of a…

   Labeling: Label Error on Declared Strength; A sealed 100-count bottle labeled with 15 mg actually contained 100 tablets of 20 mg strength of the drug product.

   FDA · DrugTeva Pharmaceuticals USA IncNationwide in the US.Official notice →
9. 2022-09-07
10. US
    Drugs & medicalClass II

    Teva Pharmaceuticals USA Inc recalls Neomycin Sulfate Tablets, USP 500 mg , 100-count bottles, Rx only, Distributed by: TEVA PHARMACEUTICALS USA, INC North Wales, PA…

    CGMP Deviations: A foreign matter identified as teflon was found in the Active Pharmaceutical Ingredient (API) used in the manufacture of Neomycin Sulfate Tablets, USP 500 mg.

    FDA · DrugTeva Pharmaceuticals USA IncNationwide within the United StatesOfficial notice →
11. 2022-08-17
12. US
    Drugs & medicalClass III

    Teva Pharmaceuticals USA Inc recalls Azacitidine for Injection 100mg/vial Lyophilized Powder, Rx Only, Mfd. in Romania By: Sindan Pharma SRL For BluePoint Laboratories,…

    Subpotent Drug - Out of specification (OOS) result obtained during monitoring stability study for Assay. Results below specification.

    FDA · DrugTeva Pharmaceuticals USA IncDistributed in OhioOfficial notice →

Other drugs & medical recalls in the United States

1. 2023-03-15
2. US
   Drugs & medicalClass III

   Akron Pharma, Inc. recalls DIBUCAINE 1% HEMORRHOIDAL OINTMENT, 1 oz. (28 gm), Manufactured for: Akron Pharma Inc. Fairfield NJ 07004, NDC 71399-2829-1

   Labeling: Incorrect or Missing Lot and/or Exp Date

   FDA · DrugAkron Pharma, Inc.Nationwide within the United StatesOfficial notice →
3. US
   Drugs & medicalClass II

   Ecometics, Inc. recalls Unguentine Original Maximum Strength Pain Relieving/Antiseptic Ointment (Camphor 3.0%, Phenol 2.5%, Tannic Acid 2.2%, Oxide 6.6%),…

   CGMP DEVIATIONS

   FDA · DrugEcometics, Inc.Nationwide within the United StatesOfficial notice →
4. US
   Drugs & medicalClass II

   Denver Solutions, LLC DBA Leiters Health recalls Phenylephrine HCl 40 mg (160 mcg/mL) added to 0.9% Sodium Chloride 250 mL IV Bag, Leiter Compounding Health 13796…

   CGMP DEVIATIONS

   FDA · DrugDenver Solutions, LLC DBA Leiters HealthNationwide within the United States including VA or other Government facilitiesOfficial notice →
5. US
   Drugs & medicalClass II

   Nutraceutical Corporation recalls NaturalCare bioAllers, Mold, Yeast and Dust, Homeopathic, Liquid Drops, 20% Alcohol, 1 FL OZ( 30mL), Mfd. for Nutraceutical Corp.…

   CGMP Deviations: Raw material recalled by repackager, due to discoloration.

   FDA · DrugNutraceutical CorporationNationwide in the USA.Official notice →
6. US
   Drugs & medicalClass II

   Amerisource Health Services LLC recalls Verapamil Hydrochloride Extended-Release Tablets, USP, 120 mg, Rx Only, 100 Tablets per Carton (10 x 10), Distributed by:…

   Failed Dissolution Specification: Out of specification dissolution results at time point zero. The OOS was above specified values.

   FDA · DrugAmerisource Health Services LLCNationwide in the USAOfficial notice →
7. US
   Drugs & medicalClass II

   Sagent Pharmaceuticals Inc recalls Heparin Sodium Injection, USP, 20,000 USP units per mL, 25 x 1 mL Multi-Dose Vials, Rx Only, For Intravenous or Subcutaneous Use, Mfd.…

   Labeling: Not elsewhere classified

   FDA · DrugSagent Pharmaceuticals IncUSA NationwideOfficial notice →